Literature DB >> 17502894

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis.

A K Kew, R Macaulay, S Burrell, S Rubin, G Dow, S Couban.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17502894     DOI： 10.1038/sj.bmt.1705709

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.

Authors:  Saravanan Kaliyaperumal; Benjamin Watkins; Prachi Sharma; Scott Furlan; Swetha Ramakrishnan; Cynthia Giver; Anapatricia Garcia; Cynthia Courtney; Heather Knight; Elizabeth Strobert; Eric Elder; Timothy Crenshaw; Bruce R Blazar; Edmund K Waller; Susan Westmoreland; Leslie S Kean
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

2.  The central nervous system is a target of acute graft versus host disease in mice.

Authors:  Steffen Hartrampf; Jarrod A Dudakov; Linda K Johnson; Odette M Smith; Jennifer Tsai; Natalie V Singer; Mallory L West; Alan M Hanash; Michael H Albert; Bingfang Liu; Miklos Toth; Marcel R M van den Brink
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

3.  Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Authors:  Nora Mirza; Manfred Zierhut; Andreas Korn; Antje Bornemann; Wichard Vogel; Barbara Schmid-Horch; Wolfgang A Bethge; Stefan Stevanović; Helmut R Salih; Lothar Kanz; Hans-Georg Rammensee; Sebastian P Haen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-10       Impact factor: 11.205

4.  Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.

Authors:  Victoria Pechey; John Parratt; Linh Vo; William Stevenson
Journal:  Int J Hematol       Date:  2014-11-22       Impact factor: 2.490

Review 5.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

6.  Neurological complications of transplantation: part I: hematopoietic cell transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-01

7.  Case report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literature.

Authors:  Mathilde Ruggiu; Wendy Cuccuini; Karima Mokhtari; Véronique Meignin; Régis Peffault de Latour; Marie Robin; Flore Sicre de Fontbrune; Aliénor Xhaard; Gérard Socié; David Michonneau
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

8.  Chronic Graft-versus-host Disease Presenting with Multiple Punctate Intracranial Lesions on Contrast-enhanced Magnetic Resonance Imaging.

Authors:  Makoto Terada; Kiyotaka Nakamagoe; Naoshi Obara; Shinichi Ogawa; Noriaki Sakamoto; Taiki Sato; Seitaro Nohara; Shigeru Chiba; Akira Tamaoka
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

Review 9.  Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yuta Kaito; Shunsuke Yui; Kazuki Inai; Daishi Onai; Ryosuke Kinoshita; Satoshi Yamanaka; Muneo Okamoto; Ryuichi Wada; Ryuji Ohashi; Koiti Inokuchi; Hiroki Yamaguchi
Journal:  Intern Med       Date:  2021-10-15       Impact factor: 1.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.